Chemiluminescence Imaging Market Overview:
The global Chemiluminescence Imaging market is estimated to be valued at US$ 3391.7 Mn in 2022 and is expected to exhibit a CAGR of 4.3% over the forecast period 2023-2030. Chemiluminescence imaging is a very sensitive technique used to detect and visualize biomolecules like DNA, proteins, small molecules etc. This technique emits light through a chemical reaction instead of an external source and has wide applications from drug discovery to molecular diagnostics.
Market key trends:
One of the key trends seen in the Chemiluminescence Imaging market is the launch of advanced products with enhanced capabilities. Vendors are focusing on developing next-generation chemiluminescence imaging systems integrated with advanced technologies like artificial intelligence and machine learning. These systems provide capabilities like automated sample analysis, advanced quantitation tools, real-time imaging through cloud connectivity and can process a large number of samples within a short duration. Such advanced products are gaining increasing adoption across various research and clinical settings due to better accuracy and high-throughput processing of samples. This is expected to drive the growth of the Chemiluminescence Imaging market during the forecast period.
Segment Analysis
The global chemiluminescence imaging market is segmented by technology, application, end-user, and region. Based on technology, the market is divided into chemiluminescence immunoassay analyzers and chemiluminescence immunoassay systems. Chemiluminescence immunoassay analyzers dominate the market and account for over 60% market share as they are widely used in clinical laboratories, research institutes, and hospitals for measuring analyte concentrations or detecting the presence of compounds in biological samples.
Key Takeaways
The Global Chemiluminescence Imaging Market Demand is expected to witness high growth, exhibiting a CAGR of 4.3% over the forecast period, due to increasing demand for diagnostic testing.
The North America region currently dominates the market, holding over 35% share due to presence of well-established healthcare infrastructure and growing usage of immunoassay technology. Asia Pacific is expected to witness fastest growth due to rising investments by key players and growing patient population.
Key players operating in the chemiluminescence imaging market are Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, Promega Corporation, PerkinElmer Inc., Abcam PLC, LI-COR Biosciences, Takara Bio, Miltenyi Biotec, GeneCopoeia Inc. These players are focusing on new product launches and business expansions to strengthen their market presence. For instance, in 2022, Thermo Fisher introduced the new imaging system ChemDoc Touch for chemiluminescence and fluorescence imaging applications.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it